Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

IRINOTECAN HYDROCHLORIDE

IRINOTECAN HYDROCHLORIDE

Standard Dose
300MG/15ML (20MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary

Approval overview IRINOTECAN HYDROCHLORIDE is listed in Drugs@FDA under application 213278 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient IRINOTECAN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 300MG/15ML (20MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2022-04-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview IRINOTECAN HYDROCHLORIDE is listed in Drugs@FDA under application 213278 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient IRINOTECAN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 300MG/15ML (20MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2022-04-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.